202 related articles for article (PubMed ID: 21914093)
1. Is there a role for rifampicin, ofloxacin and minocycline (ROM) therapy in the treatment of leprosy? Systematic review and meta-analysis.
Setia MS; Shinde SS; Jerajani HR; Boivin JF
Trop Med Int Health; 2011 Dec; 16(12):1541-51. PubMed ID: 21914093
[TBL] [Abstract][Full Text] [Related]
2. Field trials of a single dose of the combination rifampicin-ofloxacin-minocycline (ROM) for the treatment of paucibacillary leprosy.
Gupte MD
Lepr Rev; 2000 Dec; 71 Suppl():S77-80. PubMed ID: 11201893
[No Abstract] [Full Text] [Related]
3. Single-dose rifampicin, oflaxicin and minocycline (ROM) therapy for single leprosy lesions.
Ramu G
Lepr Rev; 1998 Mar; 69(1):78-82. PubMed ID: 9628098
[No Abstract] [Full Text] [Related]
4. Single-dose ROM treatment for multilesion paucibacillary leprosy--further observations.
Revankar CR; Bulchand HO; Pai VV; Ganapati R
Int J Lepr Other Mycobact Dis; 2002 Mar; 70(1):37-8. PubMed ID: 12120040
[No Abstract] [Full Text] [Related]
5. Parallel assessment of 24 monthly doses of rifampin, ofloxacin, and minocycline versus two years of World Health Organization multi-drug therapy for multi-bacillary leprosy.
Villahermosa LG; Fajardo TT; Abalos RM; Cellona RV; Balagon MV; Dela Cruz EC; Tan EV; Walsh GP; Walsh DS
Am J Trop Med Hyg; 2004 Feb; 70(2):197-200. PubMed ID: 14993633
[TBL] [Abstract][Full Text] [Related]
6. Single dose multidrug therapy for single lesion paucibacillary leprosy.
Kars HK
Indian J Lepr; 1998; 70(2):214-5; author reply 219-21. PubMed ID: 9724859
[No Abstract] [Full Text] [Related]
7. [Evaluation years in leprosy patients treated with single dose alternative scheme ROM (rifampin, ofloxacin, minocycline), after seven to nine].
Diniz LM; Catabriga MD; Souza Filho JB
Rev Soc Bras Med Trop; 2010; 43(6):695-9. PubMed ID: 21181026
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of single-dose ROM therapy plus low-dose convit vaccine as an adjuvant for treatment of paucibacillary leprosy patients with a single skin lesion.
Majumder V; Saha B; Hajra SK; Biswas SK; Saha K
Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):283-90. PubMed ID: 11221091
[TBL] [Abstract][Full Text] [Related]
9. Single dose multidrug therapy for single lesion paucibacillary leprosy.
Prasad KN
Indian J Lepr; 1998; 70(2):215-6; author reply 219-21. PubMed ID: 9724860
[No Abstract] [Full Text] [Related]
10. Multibacillary leprosy: follow up observations on 19 patients treated with 12 monthly doses of rifampicin, ofloxacin and minocycline therapy in Agra.
Kumar A; Girdhar BK
Indian J Dermatol Venereol Leprol; 2014; 80(2):156-9. PubMed ID: 24685858
[No Abstract] [Full Text] [Related]
11. Field trial on efficacy of supervised monthly dose of 600 mg rifampin, 400 mg ofloxacin and 100 mg minocycline for the treatment of leprosy; first results.
Mane I; Cartel JL; Grosset JH
Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):224-9. PubMed ID: 9251595
[TBL] [Abstract][Full Text] [Related]
12. Single dose multidrug therapy for single lesion paucibacillary leprosy.
Porichha D
Indian J Lepr; 1998; 70(2):213-4; author reply 219-21. PubMed ID: 9724858
[No Abstract] [Full Text] [Related]
13. A randomized controlled trial to compare cure and relapse rate of paucibacillary multidrug therapy with monthly rifampicin, ofloxacin, and minocycline among paucibacillary leprosy patients in Agra District, India.
Kumar A; Girdhar A; Girdhar BK
Indian J Dermatol Venereol Leprol; 2015; 81(4):356-62. PubMed ID: 26144850
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of single-dose chemotherapy (rifampicin, ofloxacin and minocycline-ROM) in PB leprosy patients with 2 to 5 skin lesions, India: randomised double-blind trial.
Manickam P; Nagaraju B; Selvaraj V; Balasubramanyam S; Mahalingam VN; Mehendale SM; Pannikar VK; Gupte MD;
Indian J Lepr; 2012; 84(3):195-207. PubMed ID: 23484334
[TBL] [Abstract][Full Text] [Related]
15. [Correlation between dose/plasma concentration and assessment of hepatic and renal changes in Wistar rats treated with the ROM scheme].
Malfará WR; Uyemura SA; Queiroz RH
Rev Soc Bras Med Trop; 2005; 38(2):167-72. PubMed ID: 15821793
[TBL] [Abstract][Full Text] [Related]
16. A comparative clinico-pathological study of single dose ROM in paucibacillary leprosy patients with 1-3 skin lesions.
Deshmukh AR; Dhurat RS; Jerajani HR
Indian J Lepr; 2003; 75(3):209-17. PubMed ID: 15267190
[TBL] [Abstract][Full Text] [Related]
17. Single-dose treatment for paucibacillary leprosy; field implications.
Revankar CR; Pai VV; Samy MS; Ganapati R
Int J Lepr Other Mycobact Dis; 1999 Sep; 67(3):312-4. PubMed ID: 10575415
[No Abstract] [Full Text] [Related]
18. Single dose multidrug therapy for single lesion paucibacillry leprosy.
Salafia A
Indian J Lepr; 1998; 70(2):216-9; author reply 219-21. PubMed ID: 9724861
[No Abstract] [Full Text] [Related]
19. World Health Organization (WHO) antibiotic regimen against other regimens for the treatment of leprosy: a systematic review and meta-analysis.
Lazo-Porras M; Prutsky GJ; Barrionuevo P; Tapia JC; Ugarte-Gil C; Ponce OJ; Acuña-Villaorduña A; Domecq JP; De la Cruz-Luque C; Prokop LJ; Málaga G
BMC Infect Dis; 2020 Jan; 20(1):62. PubMed ID: 31959113
[TBL] [Abstract][Full Text] [Related]
20. Single-dose treatment for paucibacillary leprosy; feasibility of long-term follow up.
Ganapati R; Revankar CR; Pai VV; Kingsley S
Int J Lepr Other Mycobact Dis; 1999 Sep; 67(3):308-9. PubMed ID: 10575413
[No Abstract] [Full Text] [Related]
[Next] [New Search]
